Search

Search Constraints

You searched for: Author/Creator Kelly, Virginia

Search Results

1. Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up. Issue 7 (28th April 2014)

2. Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study. Issue 11 (20th October 2018)

5. Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review. (21st August 2021)